Celyad Oncology SA announced it has taken the decision to voluntarily pause the CYAD-101-002 Phase Ib trial due to reports of two fatalities that presented with similar pulmonary findings.
[Celyad Oncology]
Sorry, but the selected Zotpress account can't be found.
